| Q45800099 | A Prospective Study of Oropharyngeal Excretion of Epstein-Barr Virus in Renal Homograft Recipients |
| Q40577317 | Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients |
| Q40647321 | Antisera against leukaemia-associated antigens on human lymphocytes |
| Q45836242 | Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome |
| Q39920080 | Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex |
| Q39974166 | Comparative studies of Epstein-barr virus strains from Ghana and the United States |
| Q45855334 | Detection of Epstein-Barr virus DNA by in Situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome |
| Q36356442 | Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome |
| Q37277452 | Detection of Epstein-Barr virus DNA in mouthwashes by hybridization. |
| Q45844566 | Detection of a second widespread strain of Epstein-Barr virus |
| Q37363180 | Epidemiologic study of a leukocyte-transforming agent in a general population |
| Q36633160 | Epstein-Barr virus and human diseases: recent advances in diagnosis |
| Q38211091 | Epstein-Barr virus and rheumatoid arthritis: cellular and molecular aspects |
| Q39494552 | Epstein-Barr virus infection and immunoregulation in man. |
| Q43619819 | Epstein-Barr virus infection in 59 orthotopic liver transplant patients |
| Q45796799 | Epstein-Barr virus infections in pregnancy: A prospective study |
| Q36782491 | Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes |
| Q45802509 | Epstein-Barr virus-related serology in marrow transplant recipients |
| Q38277473 | Epstein-Barr virus: the hematologic and oncologic consequences of virus-host interaction. |
| Q44452775 | Epstein-barr virus-induced lymphoma in a cardiac transplant recipient |
| Q39986562 | Epstein–Barr Viral Antibodies and Leukocyte-Transforming Agent in Infectious Mononucleosis |
| Q45796774 | Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells |
| Q45796867 | Epstein—Barr Virus Nuclear Antigen in a Non-Hodgkin's Lymphoma |
| Q40940945 | Evaluation of the effect of smokeless tobacco purified products and extracts on latent Epstein-Barr virus |
| Q40836695 | Formation of Paul-Bunnell antibodies by cultures of lymphocytes from infectious mononucleosis |
| Q36873148 | Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers. |
| Q33847479 | Herpesviruses |
| Q27469486 | Historical background |
| Q40080762 | Immunological control of Epstein-Barr virus infection: possible lessons for AIDS |
| Q40861706 | Infections in leukemic children: a prospective analysis |
| Q45807824 | Interferons on the Transformation of Non-T Blood Mononuclear Leukocytes by Epstein—Barr Virus |
| Q44267525 | Intrafamilial transmission of Epstein-Barr virus infections. |
| Q36436430 | Laboratory evaluations of infections in immunosuppressed transplant patients. |
| Q40009360 | Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals |
| Q39519384 | Longitudinal study of epstein-barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease |
| Q43585293 | Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjögren's syndrome |
| Q35805807 | Mononucleosis: the old myths are still useful. |
| Q45826721 | Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs |
| Q39468403 | Pathogenesis of infectious mononucleosis |
| Q37242097 | Possible involvement of IL-12 expression by Epstein-Barr virus in Sjögren syndrome |
| Q45797299 | Prevalence of Antibodies to Epstein-Barr Virus(EBV) in Childhood and Adolescence in Denmark |
| Q45797927 | Previous Epstein-Barr virus infections in children with special educational needs |
| Q40178507 | Primary epstein-barr virus infections in african infants. I. Decline of maternal antibodies and time of infection |
| Q40226268 | Prolonged survival in chronic lymphocytic leukemia: A case report |
| Q52142276 | Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity. |
| Q40093859 | The Leeuwenhoek Lecture, 1983 A prototype vaccine to prevent Epstein-Barr virus-associated tumours |
| Q28752465 | The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output |
| Q90885041 | The promise of a prophylactic Epstein-Barr virus vaccine |
| Q37658280 | Virus infections after transplantation in man. Brief review |
| Q39929487 | What Is the Determinant for Susceptibility to Infectious Mononucleosis? |